SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-027295
Filing Date
2022-09-30
Accepted
2022-09-30 17:00:48
Documents
12
Period of Report
2022-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 79893
  Complete submission text file 0001493152-22-027295.txt   264815

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lctx-20220920.xsd EX-101.SCH 3236
3 XBRL LABEL FILE lctx-20220920_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE lctx-20220920_pre.xml EX-101.PRE 22795
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4506
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-12830 | Film No.: 221284775
SIC: 2836 Biological Products, (No Diagnostic Substances)